ArticleVaccine: X2022

Antibody persistence and immune memory response following primary vaccination and boosting with live attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) in Bangladesh: A phase 4 open-label clinical trial.

K Zaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.